Delivery Order SPE2DB24D2105-SPE2DB25FAQDB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lacosamide 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,351.98 and an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,482.93 to AmerisourceBergen Drug Corp for the supply of Lacosamide 200 mg/20 ml vials. This contract is non-competitive and firm fixed price, with an ultimate completion date of September 12, 2025, just one day after the award date of September 11, 2025. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200ml quantity, with a ceiling value of $2,681.84 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Lacosamide 10 mg/ml solution in a 200 ml quantity, with a contract ceiling value of $1,051.54. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for ultimate completion by August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,280.86 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200 ml volume. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. Lacosamide is an anticonvulsant medication used primarily for the treatment of partial-onset seizures. The product will be delivered to AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Lacosamide 100 mg/10 ml cups in unit dose 10 ml vials. The contract, valued at $11,001.30, is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. This award was made without a set-aside designation through competitive procurement by the Defense Logistics Agency's Medical Supply...
- The Defense Logistics Agency Troop Support Medical awarded a $298,540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60,000 units of 150 mg lacosamide tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 28, 2023 through July 31, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 10 mg/mL Solution in a 200 mL quantity, with a ceiling value of $1,296.57. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The award carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Lacosamide 200 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $1,539.72, represents a competitive award with no set-aside designation and is scheduled for completion by June 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency Troop Support Medical awarded a $360,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60,000 units of 100mg lacosamide tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is to be completed between June 30 and July 3, 2023. No additional details were provided regarding the original solicitation or whether this award is associated with any broader contracts or vehicles. The Defense...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lacosamide 100 mg tablets in unit dose packaging (60-count), valued at $2,165.55. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as part of its comprehensive pharmaceutical supply agreement supporting military and veteran healthcare systems. The company's existing IDC with DLA serves as a global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. Lacosamide is an anticonvulsant medication commonly used in military and federal healthcare settings for seizure management and neuropathic pain treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/26/25 |